First Over-the-Counter Home Influenza and COVID Test Gets FDA Authorization
The U.S. FDA issued an emergency use authorization for the first over-the-counter at-home test that can differentiate influenza and COVID.
Read MorePosted by Andy Lundin | Feb 24, 2023 | Covid 19 |
The U.S. FDA issued an emergency use authorization for the first over-the-counter at-home test that can differentiate influenza and COVID.
Read MorePosted by Andy Lundin | Feb 23, 2023 | Cancer |
Millions of people in the U.S. continued to miss critical cancer screening tests during the second year of the COVID pandemic.
Read MorePosted by Andy Lundin | Feb 23, 2023 | Covid 19 |
Mologic announced its proprietary COVI-Go SARS-CoV-2 Ag Self-Test received EUA from the U.S. FDA for over-the-counter home use.
Read MorePosted by Andy Lundin | Feb 22, 2023 | POC Reagents & Test Kits |
Researchers have developed an ultrafast PCR technology that shortens test time by 10-fold, compared with time taken for the existing test.
Read MorePosted by Andy Lundin | Feb 21, 2023 | Amplification Technologies |
The USPTO granted Sherlock Biosciences a patent for the diagnostic use of the Cas12 enzyme, establishing it as CRISPR diagnostics provider.
Read More